|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Depreciation and amortization | |||||
| Amortization of right-of-use assets | |||||
| Unrealized loss from investments | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Accounts payable, accrued expenses and other current liabilities | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Maturities of investments | |||||
| Purchase of investments | |||||
| Purchases of property and equipment | |||||
| Net cash provided by investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Proceeds from private placement offering | |||||
| Proceeds from the sale of common stock and pre-funded warrants in public offering, net of fees | |||||
| Proceeds from sale of common stock in At-the-Market offering, net of fees | |||||
| Proceeds from exercise of warrants | |||||
| Proceeds from exercise of stock options | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
Loading...